Since feedback reactivation of MAPK signaling is important for resistance to RAF inhibitors in CRC, RAF-based inhibitor combinations were tested in BRAF-mutant CRC laboratory models, demonstrating reduced feedback activation and improved MAPK suppression.5-7. Here, BRAF is linked to colorectal carcinoma.